We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life


EffRx Pharmaceuticals Signs Exclusive License Agreement with Diurnal for the Registration and Commercialization of Alkindi® and Submits Market Authorization Application in Switzerland

See all news

Our Products

The product portfolio is led by already commercialized Binosto® for the treatment of postmenopausal osteoporosis.

See all products

Partnering with Us

Our strategy relies on partnerships for shared commercial success. We welcome you to find out more about partnering.

Get in touch